Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 754,192
  • Shares Outstanding, K 60,239
  • Annual Sales, $ 1,580 K
  • Annual Income, $ -161,340 K
  • 60-Month Beta 1.12
  • Price/Sales 480.39
  • Price/Cash Flow N/A
  • Price/Book 1.58
Trade PLRX with:

Options Overview Details

View History
  • Implied Volatility 100.89% ( +23.68%)
  • Historical Volatility 39.85%
  • IV Percentile 97%
  • IV Rank 76.83%
  • IV High 116.18% on 04/27/23
  • IV Low 50.18% on 06/21/23
  • Put/Call Vol Ratio 1.25
  • Today's Volume 9
  • Volume Avg (30-Day) 110
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 6,893
  • Open Int (30-Day) 7,131

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.76
  • Number of Estimates 7
  • High Estimate -0.66
  • Low Estimate -0.83
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -13.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.73 +1.45%
on 04/24/24
15.20 -21.71%
on 04/04/24
-2.75 (-18.77%)
since 03/22/24
3-Month
11.73 +1.45%
on 04/24/24
18.92 -37.10%
on 01/30/24
-5.44 (-31.37%)
since 01/24/24
52-Week
11.73 +1.45%
on 04/24/24
30.85 -61.43%
on 04/25/23
-18.66 (-61.06%)
since 04/24/23

Most Recent Stories

More News
Why Shares of Pliant Therapeutics Are Rising Tuesday

The company's lead therapy fared well in a phase 2a trial to treat two separate conditions.

PLRX : 11.90 (-4.95%)
Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Misses Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of -1.52% and 31.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PLRX : 11.90 (-4.95%)
BOLT : 1.2002 (+8.13%)
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates

Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -8.70% and 10.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CRDF : 4.18 (+0.24%)
PLRX : 11.90 (-4.95%)
Pliant Therapeutics, Inc. (PLRX) Reports Q4 Loss, Tops Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of -2.86% and 27.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

PLRX : 11.90 (-4.95%)
CRMD : 5.33 (-2.20%)
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.80 (-3.45%)
PLRX : 11.90 (-4.95%)
Techne (TECH) Q2 Earnings and Revenues Miss Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TECH : 63.52 (-0.27%)
PLRX : 11.90 (-4.95%)
Why Pliant Therapeutics Stock Is Skyrocketing This Week

The company's experimental idiopathic pulmonary fibrosis drug is showing a lot of promise.

PLRX : 11.90 (-4.95%)
Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More

Updates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week.

CPRX : 15.12 (+2.65%)
BLUE : 0.9229 (-4.91%)
AXLA : 0.4009 (-8.89%)
PLRX : 11.90 (-4.95%)
Pliant Therapeutics (PLRX) Surges 44% in A Week: Here's Why

Shares of Pliant Therapeutics (PLRX) have been rising since management reported positive interim data from a mid-stage study evaluating a higher dose of its lead pipeline candidate in IPF patients.

ADCT : 4.78 (-3.82%)
RCUS : 15.43 (-0.45%)
ETON : 3.21 (-2.13%)
PLRX : 11.90 (-4.95%)
Pliant Therapeutics Gaps 34% Higher: More Upside To Come?

Pliant Therapeutics zoomed 34% higher and added to that gain in the next session.This followed good news about clinical trials for a lung-condition treatment.

PLRX : 11.90 (-4.95%)
NVS : 98.35 (+1.10%)
CPRX : 15.12 (+2.65%)
NBIX : 138.97 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO,...

See More

Key Turning Points

3rd Resistance Point 13.26
2nd Resistance Point 12.92
1st Resistance Point 12.41
Last Price 11.90
1st Support Level 11.56
2nd Support Level 11.22
3rd Support Level 10.71

See More

52-Week High 30.85
Fibonacci 61.8% 23.55
Fibonacci 50% 21.29
Fibonacci 38.2% 19.03
Last Price 11.90
52-Week Low 11.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar